D
- Headquarters
- Seoul
- Business Model
- B2B
About
AI drug discovery platform
Summary
Deargen is an Artificial Intelligence company based in Seoul, South Korea.
Similar Companies

Isomorphic Labs
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Round·$2.6B·May 2026

Lila Sciences
Scientific superintelligence platform building autonomous AI labs for life, chemical, and materia...
Cambridge, United States51–200Artificial Intelligence, Biotech
Series A·$1.3B·Jun 2026

OpenAI
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate Round·$179.6B·Mar 2026
Anthropic
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+·$123.7B·May 2026
xAI
xAI is an AI platform for accelerating human scientific discovery.
San Francisco, United States201–500Artificial Intelligence, Generative AI
Series E·$41.4B·Jan 2026

Waymo
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture Round·$29.6B·Feb 2026